1607 related articles for article (PubMed ID: 17605655)
1. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
2. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
Ross RL; Serock MR; Khalil RA
Curr Cardiol Rev; 2008 Nov; 4(4):309-22. PubMed ID: 20066139
[TBL] [Abstract][Full Text] [Related]
3. Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease.
Khalil RA
Future Cardiol; 2007 May; 3(3):283-300. PubMed ID: 19804220
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
5. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
6. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
[TBL] [Abstract][Full Text] [Related]
8. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
[TBL] [Abstract][Full Text] [Related]
9. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
Khalil RA
Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
[TBL] [Abstract][Full Text] [Related]
10. Sex steroids and vascular responses in hypertension and aging.
Qiao X; McConnell KR; Khalil RA
Gend Med; 2008; 5 Suppl A():S46-64. PubMed ID: 18395683
[TBL] [Abstract][Full Text] [Related]
11. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
Dubey RK; Imthurn B; Barton M; Jackson EK
Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
13. Harnessing hormonal signaling for cardioprotection.
Ballard VL; Edelberg JM
Sci Aging Knowledge Environ; 2005 Dec; 2005(51):re6. PubMed ID: 16371658
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
15. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
17. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
18. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy in postmenopausal women.
Prelevic GM; Kocjan T; Markou A
Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
[TBL] [Abstract][Full Text] [Related]
20. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
Serock MR; Wells AK; Khalil RA
Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
